Aurelie Studeny

Aurelie Studeny has extensive experience in oncology research, currently serving as a Team Leader in Cellular Sciences- Oncology at Servier since October 2000. Key contributions include the development of cellular assays and 3D culture methodologies for oncology projects, particularly focusing on small molecules targeting aberrant signaling pathways and apoptosis. Aurelie has also worked on antibody-drug conjugates, deubiquitinase inhibitors, and novel checkpoint kinase inhibitors. Prior to Servier, Aurelie was a Technicienne superieur at Sanofi, studying intestinal passage mechanisms. Aurelie holds a Master 2 in Sciences et technologies from Pierre and Marie Curie University, completed in 2009.